Phosphoinositide 3-kinases in health and disease

Subcellular Biochemistry

Volumn 58, Issue , 2015, Pages 183-213

  Ghigo, Alessandra ^a   Morello, Fulvio ^a   Perino, Alessia ^a   Hirsch, Emilio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cancer; Glucose metabolism; Heart failure; Immunity; Inflammation

Indexed keywords

ANIMALIA;

EID: 84934873801     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-3012-0_6     Document Type: Article

References (165)

1. Agati, JM, Yeagley, D, Quinn, PG (1998) Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP-induced phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 273: pp. 18751-18759
2. Alcazar, I, Marques, M, Kumar, A, Hirsch, E, Wymann, M, Carrera, AC, Barber, DF (2007) Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation. J Exp Med 204: pp. 2977-2987
3. Ali, K, Bilancio, A, Thomas, M, Pearce, W, Gilfillan, AM, Tkaczyk, C, Kuehn, N, Gray, A, Giddings, J, Peskett, E (2004) Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431: pp. 1007-1011
4. Ali, K, Camps, M, Pearce, WP, Ji, H, Ruckle, T, Kuehn, N, Pasquali, C, Chabert, C, Rommel, C, Vanhaesebroeck, B (2008) Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo. J Immunol 180: pp. 2538-2544
5. Bachman, KE, Argani, P, Samuels, Y, Silliman, N, Ptak, J, Szabo, S, Konishi, H, Karakas, B, Blair, BG, Lin, C (2004) The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3: pp. 772-775
6. Bader, AG, Kang, S, Vogt, PK (2006) Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci USA 103: pp. 1475-1479
7. Bai, L, Wang, Y, Fan, J, Chen, Y, Ji, W, Qu, A, Xu, P, James, DE, Xu, T (2007) Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action. Cell Metab 5: pp. 47-57
8. Bandyopadhyay, GK, Yu, JG, Ofrecio, J, Olefsky, JM (2005) Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54: pp. 2351-2359
9. Baraldo, S, Lokar Oliani, K, Turato, G, Zuin, R, Saetta, M (2007) The role of lymphocytes in the pathogenesis of asthma and COPD. Curr Med Chem 14: pp. 2250-2256
10. Barber, DF, Bartolome, A, Hernandez, C, Flores, JM, Fernandez-Arias, C, Rodriguez-Borlado, L, Hirsch, E, Wymann, M, Balomenos, D, Carrera, AC (2006) Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion. J Immunol 176: pp. 589-593
11. Barberis, L, Pasquali, C, Bertschy-Meier, D, Cuccurullo, A, Costa, C, Ambrogio, C, Vilbois, F, Chiarle, R, Wymann, M, Altruda, F (2009) Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin. Eur J Immunol 39: pp. 1136-1146
12. Benistant, C, Chapuis, H, Roche, S (2000) A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells. Oncogene 19: pp. 5083-5090
13. Berenjeno, IM, Vanhaesebroeck, B (2009) PI3K regulatory subunits lose control in cancer. Cancer Cell 16: pp. 449-450
14. Berwick, DC, Dell, GC, Welsh, GI, Heesom, KJ, Hers, I, Fletcher, LM, Cooke, FT, Tavare, JM (2004) Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles. J Cell Sci 117: pp. 5985-5993
15. Bi, L, Okabe, I, Bernard, DJ, Wynshaw-Boris, A, Nussbaum, RL (1999) Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem 274: pp. 10963-10968
16. Bilancio, A, Okkenhaug, K, Camps, M, Emery, JL, Ruckle, T, Rommel, C, Vanhaesebroeck, B (2006) Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood 107: pp. 642-650
17. Bjornholm, M, Kawano, Y, Lehtihet, M, Zierath, JR (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: pp. 524-527
18. Bohnacker T, Marone R, Collmann E, Calvez R, Hirsch E, Wymann MP (2009) PI3Kgamma adaptor subunits define coupling to degranulation and cell motility by distinct PtdIns(3,4,5)P3 pools in mast cells. Sci Signal 2:ra27
19. Borlado, LR, Redondo, C, Alvarez, B, Jimenez, C, Criado, LM, Flores, J, Marcos, MA, Martinez, AC, Balomenos, D, Carrera, AC (2000) Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. Faseb J 14: pp. 895-903
20. Brachmann, SM, Ueki, K, Engelman, JA, Kahn, RC, Cantley, LC (2005) Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Mol Cell Biol 25: pp. 1596-1607
21. Brennan, FM, Feldmann, M (1996) Cytokines in autoimmunity. Curr Opin Immunol 8: pp. 872-877
22. Bristow, MR, Ginsburg, R, Minobe, W, Cubicciotti, RS, Sageman, WS, Lurie, K, Billingham, ME, Harrison, DC, Stinson, EB (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307: pp. 205-211
23. Brodde, OE, Bruck, H, Leineweber, K (2006) Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci 100: pp. 323-337
24. Camps, M, Ruckle, T, Ji, H, Ardissone, V, Rintelen, F, Shaw, J, Ferrandi, C, Chabert, C, Gillieron, C, Francon, B (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nature medicine 11: pp. 936-943
25. Carvalho, S, Milanezi, F, Costa, JL, Amendoeira, I, Schmitt, F (2010) PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer. Virchows Arch 456: pp. 235-243
26. Chagpar, RB, Links, PH, Pastor, MC, Furber, LA, Hawrysh, AD, Chamberlain, MD, Anderson, DH (2010) Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 107: pp. 5471-5476
27. Chaussade, C, Cho, K, Mawson, C, Rewcastle, GW, Shepherd, PR (2009) Functional differences between two classes of oncogenic mutation in the PIK3CA gene. Biochem Biophys Res Commun 381: pp. 577-581
28. Chen, D, Mauvais-Jarvis, F, Bluher, M, Fisher, SJ, Jozsi, A, Goodyear, LJ, Ueki, K, Kahn, CR (2004) p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol Cell Biol 24: pp. 320-329
29. Chen, S, Wasserman, DH, MacKintosh, C, Sakamoto, K (2011) Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metab 13: pp. 68-79
30. Cho, H, Mu, J, Kim, JK, Thorvaldsen, JL, Chu, Q, Crenshaw, EB, Kaestner, KH, Bartolomei, MS, Shulman, GI, Birnbaum, MJ (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: pp. 1728-1731
31. Chu, G, Lester, JW, Young, KB, Luo, W, Zhai, J, Kranias, EG (2000) A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists. J Biol Chem 275: pp. 38938-38943
32. Ciraolo E, Iezzi M, Marone R, Marengo S, Curcio C, Costa C, Azzolino O, Gonella C, Rubinetto C Wu H et al (2008) Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal 1:ra3
33. Clayton, E, Bardi, G, Bell, SE, Chantry, D, Downes, CP, Gray, A, Humphries, LA, Rawlings, D, Reynolds, H, Vigorito, E (2002) A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 196: pp. 753-763
34. Condliffe, AM, Davidson, K, Anderson, KE, Ellson, CD, Crabbe, T, Okkenhaug, K, Vanhaesebroeck, B, Turner, M, Webb, L, Wymann, MP(2005) Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 106: pp. 1432-1440
35. Condorelli, G, Drusco, A, Stassi, G, Bellacosa, A, Roncarati, R, Iaccarino, G, Russo, MA, Gu, Y, Dalton, N, Chung, C (2002) Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 99: pp. 12333-12338
36. Conti, M, Beavo, J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76: pp. 481-511
37. Costa, C, Barberis, L, Ambrogio, C, Manazza, AD, Patrucco, E, Azzolino, O, Neilsen, PO, Ciraolo, E, Altruda, F, Prestwich, GD (2007) Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma. Proc Natl Acad Sci USA 104: pp. 14354-14359
38. Crackower, MA, Oudit, GY, Kozieradzki, I, Sarao, R, Sun, H, Sasaki, T, Hirsch, E, Suzuki, A, Shioi, T, Irie-Sasaki, J (2002) Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110: pp. 737-749
39. Damilano, F, Franco, I, Perrino, C, Schaefer, K, Azzolino, O, Carnevale, D, Cifelli, G, Carullo, P, Ragona, R, Ghigo, A (2011) Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase {gamma} activity in pressure overload-induced cardiac failure. Circulation 123: pp. 391-399
40. DeBosch, B, Treskov, I, Lupu, TS, Weinheimer, C, Kovacs, A, Courtois, M, Muslin, AJ (2006) Akt1 is required for physiological cardiac growth. Circulation 113: pp. 2097-2104
41. Gorter, DJ, Beuling, EA, Kersseboom, R, Middendorp, S, Gils, JM, Hendriks, RW, Pals, ST, Spaargaren, M (2007) Bruton’s tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing. Immunity 26: pp. 93-104
42. Cristofano, A, Kotsi, P, Peng, YF, Cordon-Cardo, C, Elkon, KB, Pandolfi, PP (1999) Impaired Fas response and autoimmunity in Pten +/− mice. Science 285: pp. 2122-2125
43. Doherty, DE (2004) The pathophysiology of airway dysfunction. Am J Med 117: pp. 11S-23S
44. Doukas, J, Eide, L, Stebbins, K, Racanelli-Layton, A, Dellamary, L, Martin, M, Dneprovskaia, E, Noronha, G, Soll, R, Wrasidlo, W (2009) Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100–115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease. J Pharmacol Exp Ther 328: pp. 758-765
45. Duan, W, Datiles, AM, Leung, BP, Vlahos, CJ, Wong, WS (2005) An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol 5: pp. 495-502
46. Edling, CE, Selvaggi, F, Buus, R, Maffucci, T, Di Sebastiano, P, Friess, H, Innocenti, P, Kocher, HM, Falasca, M (2010) Key role of phosphoinositide 3-kinase class IB in pancreatic cancer. Clin Cancer Res 16: pp. 4928-4937
47. Edwards, SW, Hallett, MB (1997) Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunology today 18: pp. 320-324
48. Engelman, JA, Luo, J, Cantley, LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: pp. 606-619
49. Ezeamuzie, CI, Sukumaran, J, Philips, E (2001) Effect of wortmannin on human eosinophil responses in vitro and on bronchial inflammation and airway hyperresponsiveness in Guinea pigs in vivo. Am J Respir Crit Care Med 164: pp. 1633-1639
50. Farese, RV, Sajan, MP, Standaert, ML (2005) Atypical protein kinase C in insulin action and insulin resistance. Biochem Soc Trans 33: pp. 350-353
51. Farese, RV, Sajan, MP, Yang, H, Li, P, Mastorides, S, Gower, WR, Nimal, S, Choi, CS, Kim, S, Shulman, GI (2007) Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J Clin Invest 117: pp. 2289-2301
52. Farghaly, HS, Blagbrough, IS, Medina-Tato, DA, Watson, ML (2008) Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism. Molecular pharmacology 73: pp. 1530-1537
53. Ferguson, GJ, Milne, L, Kulkarni, S, Sasaki, T, Walker, S, Andrews, S, Crabbe, T, Finan, P, Jones, G, Jackson, S (2007) PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis. Nature Cell Biol 9: pp. 86-91
54. Folli, F, Saad, MJ, Backer, JM, Kahn, CR (1993) Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 92: pp. 1787-1794
55. Fougerat, A, Gayral, S, Gourdy, P, Schambourg, A, Ruckle, T, Schwarz, MK, Rommel, C, Hirsch, E, Arnal, JF, Salles, JP (2008) Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation 117: pp. 1310-1317
56. Foukas, LC, Claret, M, Pearce, W, Okkenhaug, K, Meek, S, Peskett, E, Sancho, S, Smith, AJ, Withers, DJ, Vanhaesebroeck, B (2006) Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441: pp. 366-370
57. Fruman, DA, Cantley, LC (2002) Phosphoinositide 3-kinase in immunological systems. Sem Immunol 14: pp. 7-18
58. Fruman, DA, Mauvais-Jarvis, F, Pollard, DA, Yballe, CM, Brazil, D, Bronson, RT, Kahn, CR, Cantley, LC (2000) Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat Genet 26: pp. 379-382
59. George, S, Rochford, JJ, Wolfrum, C, Gray, SL, Schinner, S, Wilson, JC, Soos, MA, Murgatroyd, PR, Williams, RM, Acerini, CL (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304: pp. 1325-1328
60. Ghigo A, Hirsch E (2011) PI3Kgamma mediates cardiac cAMP compartmentalization through scaffloding of distinct phosphodiesterases. In Heart Failure Winter Meeting (Les Diablerets)
61. Goodyear, LJ, Giorgino, F, Sherman, LA, Carey, J, Smith, RJ, Dohm, GL (1995) Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95: pp. 2195-2204
62. Gymnopoulos, M, Elsliger, MA, Vogt, PK (2007) Rare cancer-specific mutations in PIK3CA show gain of function. Proc Natl Acad Sci USA 104: pp. 5569-5574
63. Harris, ED (1990) Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322: pp. 1277-1289
64. Hayer, S, Pundt, N, Peters, MA, Wunrau, C, Kuhnel, I, Neugebauer, K, Strietholt, S, Zwerina, J, Korb, A, Penninger, J (2009) PI3K{gamma} regulates cartilage damage in chronic inflammatory arthritis. Faseb J 23: pp. 4288-4298
65. Henley, T, Kovesdi, D, Turner, M (2008) B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta. Eur J Immunol 38: pp. 3543-3548
66. Hill, KM, Kalifa, S, Das, JR, Bhatti, T, Gay, M, Williams, D, Taliferro-Smith, L, Marzo, AM (2010) The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells. Prostate 70: pp. 755-764
67. Hirsch, E, Katanaev, VL, Garlanda, C, Azzolino, O, Pirola, L, Silengo, L, Sozzani, S, Mantovani, A, Altruda, F, Wymann, MP (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287: pp. 1049-1053
68. Hirsch, E, Lembo, G, Montrucchio, G, Rommel, C, Costa, C, Barberis, L (2006) Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. Thromb Haemost 95: pp. 29-35
69. Hirsch, E, Braccini, L, Ciraolo, E, Morello, F, Perino, A (2009) Twice upon a time: PI3K’s secret double life exposed. Trends Biochem Sci 34: pp. 244-248
70. Imamura, T, Huang, J, Usui, I, Satoh, H, Bever, J, Olefsky, JM (2003) Insulin-induced GLUT4 translocation involves protein kinase C-lambda-mediated functional coupling between Rab4 and the motor protein kinesin. Mol Cell Biol 23: pp. 4892-4900
71. Inoue, G, Cheatham, B, Emkey, R, Kahn, CR (1998) Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J Biol Chem 273: pp. 11548-11555
72. Jaiswal, BS, Janakiraman, V, Kljavin, NM, Chaudhuri, S, Stern, HM, Wang, W, Kan, Z, Dbouk, HA, Peters, BA, Waring, P (2009) Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell 16: pp. 463-474
73. Ji, H, Rintelen, F, Waltzinger, C, Bertschy Meier, D, Bilancio, A, Pearce, W, Hirsch, E, Wymann, MP, Ruckle, T, Camps, M (2007) Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood 110: pp. 2940-2947
74. Jia, S, Liu, Z, Zhang, S, Liu, P, Zhang, L, Lee, SH, Zhang, J, Signoretti, S, Loda, M, Roberts, TM (2008) Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 454: pp. 776-779
75. Jou, ST, Carpino, N, Takahashi, Y, Piekorz, R, Chao, JR, Carpino, N, Wang, D, Ihle, JN (2002) Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 22: pp. 8580-8591
76. Kahn, CR (1994) Banting lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: pp. 1066-1084
77. Kang, S, Denley, A, Vanhaesebroeck, B, Vogt, PK (2006) Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc Natl Acad Sci USA 103: pp. 1289-1294
78. Kerfant, BG, Zhao, D, Lorenzen-Schmidt, I, Wilson, LS, Cai, S, Chen, SR, Maurice, DH, Backx, PH (2007) PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes. Circ Res 101: pp. 400-408
79. Kerouz, NJ, Horsch, D, Pons, S, Kahn, CR (1997) Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100: pp. 3164-3172
80. Knight, ZA, Gonzalez, B, Feldman, ME, Zunder, ER, Goldenberg, DD, Williams, O, Loewith, R, Stokoe, D, Balla, A, Toth, B (2006) A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125: pp. 733-747
81. Knobbe, CB, Reifenberger, G (2003) Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13: pp. 507-518
82. Kotani, K, Ogawa, W, Hino, Y, Kitamura, T, Ueno, H, Sano, W, Sutherland, C, Granner, DK, Kasuga, M (1999) Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Clambda do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 274: pp. 21305-21312
83. Kurlawalla-Martinez, C, Stiles, B, Wang, Y, Devaskar, SU, Kahn, BB, Wu, H (2005) Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol 25: pp. 2498-2510
84. Laffargue, M, Calvez, R, Finan, P, Trifilieff, A, Barbier, M, Altruda, F, Hirsch, E, Wymann, MP (2002) Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 16: pp. 441-451
85. Lee, KS, Lee, HK, Hayflick, JS, Lee, YC, Puri, KD (2006) Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. Faseb J 20: pp. 455-465
86. Lee, SH, Poulogiannis, G, Pyne, S, Jia, S, Zou, L, Signoretti, S, Loda, M, Cantley, LC, Roberts, TM (2010) A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in mice. Proc Natl Acad Sci USA 107: pp. 11002-11007
87. Lefkowitz, RJ, Whalen, EJ (2004) beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol 16: pp. 162-168
88. Li, Z, Jiang, H, Xie, W, Zhang, Z, Smrcka, AV, Wu, D (2000) Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287: pp. 1046-1049
89. Lim, DH, Cho, JY, Song, DJ, Lee, SY, Miller, M, Broide, DH (2009) PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am J Physiol 296: pp. L210-L219
90. Lin, RC, Weeks, KL, Gao, XM, Williams, RB, Bernardo, BC, Kiriazis, H, Matthews, VB, Woodcock, EA, Bouwman, RD, Mollica, JP (2010) PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 30: pp. 724-732
91. Link, W, Rosado, A, Fominaya, J, Thomas, JE, Carnero, A (2005) Membrane localization of all class I PI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt. J Cell Biochem 95: pp. 979-989
92. Liu, K, Wakeland, EK (2001) Delineation of the pathogenesis of systemic lupus erythematosus by using murine models. Adv Exp Med Biol 490: pp. 1-6
93. Liu, L, Puri, KD, Penninger, JM, Kubes, P (2007) Leukocyte PI3Kgamma and PI3Kdelta have temporally distinct roles for leukocyte recruitment in vivo. Blood 110: pp. 1191-1198
94. Liu, D, Zhang, T, Marshall, AJ, Okkenhaug, K, Vanhaesebroeck, B, Uzonna, JE (2009) The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J Immunol 183: pp. 1921-1933
95. Locke, NR, Patterson, SJ, Hamilton, MJ, Sly, LM, Krystal, G, Levings, MK (2009) SHIP regulates the reciprocal development of T regulatory and Th17 cells. J Immunol 183: pp. 975-983
96. Maffucci, T, Brancaccio, A, Piccolo, E, Stein, RC, Falasca, M (2003) Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO J 22: pp. 4178-4189
97. Marwick, JA, Caramori, G, Stevenson, CS, Casolari, P, Jazrawi, E, Barnes, PJ, Ito, K, Adcock, IM, Kirkham, PA, Papi, A (2009) Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med 179: pp. 542-548
98. Marwick, JA, Caramori, G, Casolari, P, Mazzoni, F, Kirkham, PA, Adcock, IM, Chung, KF, Papi, A (2010) A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 125: pp. 1146-1153
99. Marx, SO, Reiken, S, Hisamatsu, Y, Jayaraman, T, Burkhoff, D, Rosemblit, N, Marks, AR (2000) PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101: pp. 365-376
100. Matsui, T, Li, L, Wu, JC, Cook, SA, Nagoshi, T, Picard, MH, Liao, R, Rosenzweig, A (2002) Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277: pp. 22896-22901
101. McMullen, JR, Shioi, T, Zhang, L, Tarnavski, O, Sherwood, MC, Kang, PM, Izumo, S (2003) Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci USA 100: pp. 12355-12360
102. McMullen, JR, Amirahmadi, F, Woodcock, EA, Schinke-Braun, M, Bouwman, RD, Hewitt, KA, Mollica, JP, Zhang, L, Zhang, Y, Shioi, T (2007) Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 104: pp. 612-617
103. Mishra, RK, Scaife, JE, Harb, Z, Gray, BC, Djukanovic, R, Dent, G (2005) Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). Allergy 60: pp. 1204-1207
104. Morrow, CJ, Gray, A, Dive, C (2005) Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA. FEBS Lett 579: pp. 5123-5128
105. Myers, MG, White, MF (1993) The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42: pp. 643-650
106. Myers, MG, Backer, JM, Sun, XJ, Shoelson, S, Hu, P, Schlessinger, J, Yoakim, M, Schaffhausen, B, White, MF (1992) IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci U S A 89: pp. 10350-10354
107. Prasad, SV, Esposito, G, Mao, L, Koch, WJ, Rockman, HA (2000) Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem 275: pp. 4693-4698
108. Prasad, SV, Barak, LS, Rapacciuolo, A, Caron, MG, Rockman, HA (2001) Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. J Biol Chem 276: pp. 18953-18959
109. Prasad, SV, Laporte, SA, Chamberlain, D, Caron, MG, Barak, L, Rockman, HA (2002) Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol 158: pp. 563-575
110. Nakae, J, Kitamura, T, Silver, DL, Accili, D (2001) The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108: pp. 1359-1367
111. Nienaber, JJ, Tachibana, H, Naga Prasad, SV, Esposito, G, Wu, D, Mao, L, Rockman, HA (2003) Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112: pp. 1067-1079
112. Nombela-Arrieta, C, Lacalle, RA, Montoya, MC, Kunisaki, Y, Megias, D, Marques, M, Carrera, AC, Manes, S, Fukui, Y, Martinez, AC (2004) Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 21: pp. 429-441
113. Oak, JS, Deane, JA, Kharas, MG, Luo, J, Lane, TE, Cantley, LC, Fruman, DA (2006) Sjogren’s syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci USA 103: pp. 16882-16887
114. Okada, T, Sakuma, L, Fukui, Y, Hazeki, O, Ui, M (1994) Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J Biol Chem 269: pp. 3563-3567
115. Okkenhaug, K, Bilancio, A, Farjot, G, Priddle, H, Sancho, S, Peskett, E, Pearce, W, Meek, SE, Salpekar, A, Waterfield, MD (2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297: pp. 1031-1034
116. Okkenhaug, K, Patton, DT, Bilancio, A, Garcon, F, Rowan, WC, Vanhaesebroeck, B (2006) The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J Immunol 177: pp. 5122-5128
117. Omori, SA, Cato, MH, Anzelon-Mills, A, Puri, KD, Shapiro-Shelef, M, Calame, K, Rickert, RC (2006) Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 25: pp. 545-557
118. Palframan, RT, Collins, PD, Severs, NJ, Rothery, S, Williams, TJ, Rankin, SM (1998) Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 188: pp. 1621-1632
119. Patrucco, E, Notte, A, Barberis, L, Selvetella, G, Maffei, A, Brancaccio, M, Marengo, S, Russo, G, Azzolino, O, Rybalkin, SD (2004) PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118: pp. 375-387
120. Patton, DT, Garden, OA, Pearce, WP, Clough, LE, Monk, CR, Leung, E, Rowan, WC, Sancho, S, Walker, LS, Vanhaesebroeck, B (2006) Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4 + CD25 + Foxp3 + regulatory T cells. J Immunol 177: pp. 6598-6602
121. Perino, A, Ghigo, A, Ferrero, E, Morello, F, Santulli, G, Baillie, GS, Damilano, F, Dunlop, AJ, Pawson, C, Walser, R (2011) Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. Mol Cell 42: pp. 84-95
122. Perrino, C, Naga Prasad, SV, Patel, M, Wolf, MJ, Rockman, HA (2005a) Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression. J Am Coll Cardiol 45: pp. 1862-1870
123. Perrino, C, Naga Prasad, SV, Schroder, JN, Hata, JA, Milano, C, Rockman, HA (2005b) Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex. Circulation 111: pp. 2579-2587
124. Phu, T, Haeryfar, SM, Musgrave, BL, Hoskin, DW (2001) Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro. J Leukoc Biol 69: pp. 803-814
125. Pinho, V, Souza, DG, Barsante, MM, Hamer, FP, Freitas, MS, Rossi, AG, Teixeira, MM (2005) Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J Leukoc Biol 77: pp. 800-810
126. Puri, KD, Doggett, TA, Douangpanya, J, Hou, Y, Tino, WT, Wilson, T, Graf, T, Clayton, E, Turner, M, Hayflick, JS (2004) Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. Blood 103: pp. 3448-3456
127. Puri, KD, Doggett, TA, Huang, CY, Douangpanya, J, Hayflick, JS, Turner, M, Penninger, J, Diacovo, TG (2005) The role of endothelial PI3Kgamma activity in neutrophil trafficking. Blood 106: pp. 150-157
128. Randis, TM, Puri, KD, Zhou, H, Diacovo, TG (2008) Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils. Eur J Immunol 38: pp. 1215-1224
129. Reif, K, Okkenhaug, K, Sasaki, T, Penninger, JM, Vanhaesebroeck, B, Cyster, JG (2004) Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 173: pp. 2236-2240
130. Rockman, HA, Koch, WJ, Lefkowitz, RJ (2002) Seven-transmembrane-spanning receptors and heart function. Nature 415: pp. 206-212
131. Rommel, C, Camps, M, Ji, H (2007) PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?. Nat Rev Immunol 7: pp. 191-201
132. Saal, LH, Holm, K, Maurer, M, Memeo, L, Su, T, Wang, X, Yu, JS, Malmstrom, PO, Mansukhani, M, Enoksson, J (2005) PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res 65: pp. 2554-2559
133. Sadhu, C, Masinovsky, B, Dick, K, Sowell, CG, Staunton, DE (2003) Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 170: pp. 2647-2654
134. Samuels, Y, Wang, Z, Bardelli, A, Silliman, N, Ptak, J, Szabo, S, Yan, H, Gazdar, A, Powell, SM, Riggins, GJ (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304: pp. 554
135. Sano, H, Kane, S, Sano, E, Miinea, CP, Asara, JM, Lane, WS, Garner, CW, Lienhard, GE (2003) Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278: pp. 14599-14602
136. Sasaki, T, Irie-Sasaki, J, Jones, RG, Oliveira-dos-Santos, AJ, Stanford, WL, Bolon, B, Wakeham, A, Itie, A, Bouchard, D, Kozieradzki, I (2000) Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 287: pp. 1040-1046
137. Scott, JD, Pawson, T (2009) Cell signaling in space and time: where proteins come together and when they’re apart. Science 326: pp. 1220-1224
138. Shepherd, PR (2005) Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiol Scand 183: pp. 3-12
139. Shi, J, Cinek, T, Truitt, KE, Imboden, JB (1997) Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4 + T cells. J Immunol 158: pp. 4688-4695
140. Shioi, T, Kang, PM, Douglas, PS, Hampe, J, Yballe, CM, Lawitts, J, Cantley, LC, Izumo, S (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19: pp. 2537-2548
141. Silvestris, N, Tommasi, S, Petriella, D, Santini, D, Fistola, E, Russo, A, Numico, G, Tonini, G, Maiello, E, Colucci, G (2009) The dark side of the moon: the PI3K/PTEN/AKT pathway in colorectal carcinoma. Oncology 77: pp. 69-74
142. Sinclair, LV, Finlay, D, Feijoo, C, Cornish, GH, Gray, A, Ager, A, Okkenhaug, K, Hagenbeek, TJ, Spits, H, Cantrell, DA (2008) Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 9: pp. 513-521
143. Siragusa, M, Katare, R, Meloni, M, Damilano, F, Hirsch, E, Emanueli, C, Madeddu, P (2010) Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res 106: pp. 757-768
144. Skeberdis, VA, Gendviliene, V, Zablockaite, D, Treinys, R, Macianskiene, R, Bogdelis, A, Jurevicius, J, Fischmeister, R (2008) beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2 + current. J Clin Invest 118: pp. 3219-3227
145. Smith, LD, Hickman, ES, Parry, RV, Westwick, J, Ward, SG (2007) PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA. Cell Signal 19: pp. 2528-2539
146. Sopasakis, VR, Liu, P, Suzuki, R, Kondo, T, Winnay, J, Tran, TT, Asano, T, Smyth, G, Sajan, MP, Farese, RV (2010) Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation. Cell Metab 11: pp. 220-230
147. Stelzer, JE, Patel, JR, Walker, JW, Moss, RL (2007) Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ Res 101: pp. 503-511
148. Stenkula, KG, Lizunov, VA, Cushman, SW, Zimmerberg, J (2010) Insulin controls the spatial distribution of GLUT4 on the cell surface through regulation of its postfusion dispersal. Cell Metab 12: pp. 250-259
149. Sujobert, P, Bardet, V, Cornillet-Lefebvre, P, Hayflick, JS, Prie, N, Verdier, F, Vanhaesebroeck, B, Muller, O, Pesce, F, Ifrah, N (2005) Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Blood 106: pp. 1063-1066
150. Sun, XJ, Crimmins, DL, Myers, MG, Miralpeix, M, White, MF (1993) Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol 13: pp. 7418-7428
151. Szekanecz, Z, Kim, J, Koch, AE (2003) Chemokines and chemokine receptors in rheumatoid arthritis. Sem Immunol 15: pp. 15-21
152. Takeda, M, Ito, W, Tanabe, M, Ueki, S, Kato, H, Kihara, J, Tanigai, T, Chiba, T, Yamaguchi, K, Kayaba, H (2009) Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice. J Allergy Clin Immunol 123: pp. 805-812
153. Taniguchi, CM, Emanuelli, B, Kahn, CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7: pp. 85-96
154. Terauchi, Y, Tsuji, Y, Satoh, S, Minoura, H, Murakami, K, Okuno, A, Inukai, K, Asano, T, Kaburagi, Y, Ueki, K (1999) Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet 21: pp. 230-235
155. Tigani, B, Hannon, JP, Mazzoni, L, Fozard, JR (2001) Effects of wortmannin on airways inflammation induced by allergen in actively sensitised Brown Norway rats. Eur J Pharmacol 433: pp. 217-223
156. Tkaczyk, C, Beaven, MA, Brachman, SM, Metcalfe, DD, Gilfillan, AM (2003) The phospholipase C gamma 1-dependent pathway of Fc epsilon RI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J Biol Chem 278: pp. 48474-48484
157. Ueki, K, Yballe, CM, Brachmann, SM, Vicent, D, Watt, JM, Kahn, CR, Cantley, LC (2002) Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 99: pp. 419-424
158. Vasudevan, KM, Barbie, DA, Davies, MA, Rabinovsky, R, McNear, CJ, Kim, JJ, Hennessy, BT, Tseng, H, Pochanard, P, Kim, SY (2009) AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 16: pp. 21-32
159. Velasco, A, Bussaglia, E, Pallares, J, Dolcet, X, Llobet, D, Encinas, M, Llecha, N, Palacios, J, Prat, J, Matias-Guiu, X (2006) PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations. Hum Pathol 37: pp. 1465-1472
160. Voigt, P, Dorner, MB, Schaefer, M (2006) Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase gamma that is highly expressed in heart and interacts with PDE3B. J Biol Chem 281: pp. 9977-9986
161. Webb, LM, Vigorito, E, Wymann, MP, Hirsch, E, Turner, M (2005) Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase. J Immunol 175: pp. 2783-2787
162. Wee, S, Wiederschain, D, Maira, SM, Loo, A, Miller, C, DeBeaumont, R, Stegmeier, F, Yao, YM, Lengauer, C (2008) PTEN-deficient cancers depend on PIK3CB. Proc Natl Acad Sci U S A 105: pp. 13057-13062
163. Wong, KK, Engelman, JA, Cantley, LC (2010) Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 20: pp. 87-90
164. Zhang, TT, Okkenhaug, K, Nashed, BF, Puri, KD, Knight, ZA, Shokat, KM, Vanhaesebroeck, B, Marshall, AJ (2008) Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. J Allergy Clin Immunol 122: pp. e812
165. Zhao, L, Vogt, PK (2008) Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms. Proc Natl Acad Sci USA 105: pp. 2652-2657